By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Probiodrug AG 

Weinbergweg 22

Halle (Saale)    D-06120  Germany
Phone: 49-345-5559900 Fax: 49-345-5559901


Company News
Probiodrug AG To Present Data On Its Anti-Pglu-3 Abeta Monoclonal Antibody At The 12th International Conference On Alzheimer’s And Parkinson’s Diseases (AD/PDTM 2015), Nice 3/20/2015 9:25:56 AM
Probiodrug AG Announces Enrolment Of First Patient In Phase 2 Study Of Novel Treatment For Alzheimer’s Disease 3/9/2015 10:35:50 AM
Probiodrug AG Release: Data On Glutaminyl Cyclases (Qcs) In Its Relation To Alzheimer’s Disease (AD) Published In Acta Neuropathologica 3/3/2015 7:52:36 AM
German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO 9/29/2014 8:02:54 AM
Probiodrug AG Presents Pre-clinical And Clinical Findings Of PQ912, A QC-Inhibitor For Alzheimer's Disease 7/31/2014 11:47:53 AM
Probiodrug AG Presents Development Overview Of PQ912, Probiodrug’s QC-Inhibitor For Alzheimer’s Disease 7/10/2014 6:20:59 AM
Probiodrug AG To Present At 2014 Asia Biotech Invest Conference 6/2/2014 7:40:33 AM
Probiodrug AG To Present At Annual BioEquity Europe Conference 5/19/2014 6:45:14 AM
Probiodrug AG And VU University Medical Center In Amsterdam To Collaborate On The Development Of Alzheimer's Disease Biomarker Assays 1/10/2014 8:42:13 AM
Probiodrug AG Divests Its CDK9 Inhibitor Program To AstraZeneca PLC (AZN) For Undisclosed Price 1/3/2014 7:01:22 AM